@article { , title = {Patient survey examining the experience of care of a hospital-based opt-out tobacco dependency treatment service (the CURE Project)}, abstract = {INTRODUCTION: Treating tobacco dependency in patients admitted to hospital is a key priority in the National Health Service long-term plan. This service evaluation assessed the perception, needs and experience of care within an opt-out hospital-based tobacco dependency treatment service (the Conversation, Understand, Replace, Experts and Evidence Base (CURE) team) in North-West England. METHODS: A survey was offered to all eligible patients between 1 July 2020 and 30 September 2020. Eligibility criteria were adult patients identified as an active smoker being approached by the CURE team as part of the standard opt-out service model, on a non-covid ward without a high suspicion of COVID-19 infection and able to read and write in English. RESULTS: 106 completed surveys were evaluated. Participants demonstrated high levels of tobacco dependency with an average of 37 years smoking history and 66\% describing the onset of cravings within 30 min of hospital admission. The average number quit attempts in the previous 12 months was 1.3 but only 9\% had used the most effective National Institute for Health and Care Excellence (NICE) recommended treatments. 100\% felt the opt-out service model was appropriate and 96\% stated the treatment and support they had received had prompted them to consider a further quit attempt. 82\% of participants rated their experience of care as 9/10 or 10/10. Participants wanted a broad range of support post discharge with the most popular option being with their general practitioner. 66\% and 65\% of participants would have been interested in a vaping kit as stop smoking intervention and support vaping-friendly hospital grounds respectively. CONCLUSION: These results suggest this hospital-based, opt-out tobacco dependency treatment service delivers high-quality experience of care and meets the needs of the patients it serves. It also highlights the opportunity to enhance outcomes by providing access to NICE recommended most-effective interventions (varenicline, vaping and combination nicotine replacement therapy) and providing flexible, individualised discharge pathways.}, doi = {10.1136/bmjresp-2022-001334}, eissn = {2052-4439}, issue = {1}, journal = {BMJ Open Respiratory Research}, publicationstatus = {Published}, publisher = {BMJ}, url = {https://nottingham-repository.worktribe.com/output/13166865}, volume = {9}, keyword = {Pulmonary and Respiratory Medicine}, year = {2022}, author = {Hryhorskyj, Lynn and Howle, Freya and Groom, Kathryn and Moore, Ryan and Clegg, Hannah and Shackley, David and Pearce, Cheryl and Baugh, Monique and Rutherford, Michael and Huddart, Helen and Mawson, Alyshia and Manley, Emily and Hewitt, Kath and Coyne, Jane and Benbow, Elizabeth and Crossfield, Andrea and Murray, Rachael L and Evison, Matthew} }